Cantor Fitzgerald Starts Adverum Biotechnologies (ADVM) at Neutral

November 5, 2018 2:13 AM EST Send to a Friend
Cantor Fitzgerald analyst Charles Duncan initiates coverage on Adverum Biotechnologies ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login